
Apelin-13: A promising biomarker for multiple sclerosis?
Author(s) -
Murat Alpua,
Yakup Türkel,
Ersel Dağ,
Üçler Kısa
Publication year - 2018
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_377_17
Subject(s) - apelin , medicine , multiple sclerosis , biomarker , expanded disability status scale , disease , gastroenterology , oncology , immunology , receptor , biochemistry , chemistry
Recent studies have shown that Apelin 13 may have a neuroprotective property. Therefore it can be used as a biomarker for multiple sclerosis. Our purpose to assess serum apelin-13 levels in adult patients with multiple sclerosis and healthy controls.